Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results Pharmaceutical Investing
CymaBay Reports Fourth Quarter and Fiscal 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease Pharmaceutical Investing
Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Fragile X Syndrome Pharmaceutical Investing
